Similar articles for PMID: 17488796

Year	Number of Results
1991	2
1993	1
1994	1
1998	1
1999	1
2000	3
2001	4
2002	2
2003	5
2004	5
2005	10
2006	9
2007	15
2008	12
2009	9
2010	3
2011	7
2012	9
2013	9
2014	12
2015	12
2016	9
2017	8
2018	10
2019	8
2020	6
2021	2
2022	3
2023	1
2024	0

1

BRAF mutations in papillary thyroid carcinomas inhibit genes involved in iodine metabolism.

Durante C, Puxeddu E, Ferretti E, Morisi R, Moretti S, Bruno R, Barbi F, Avenia N, Scipioni A, Verrienti A, Tosi E, Cavaliere A, Gulino A, Filetti S, Russo D. Durante C, et al. J Clin Endocrinol Metab. 2007 Jul;92(7):2840-3. doi: 10.1210/jc.2006-2707. Epub 2007 May 8. J Clin Endocrinol Metab. 2007. PMID: 17488796

2

Recapitulating thyroid cancer histotypes through engineering embryonic stem cells.

Veschi V, Turdo A, Modica C, Verona F, Di Franco S, Gaggianesi M, Tirrò E, Di Bella S, Iacono ML, Pantina VD, Porcelli G, Mangiapane LR, Bianca P, Rizzo A, Sciacca E, Pillitteri I, Vella V, Belfiore A, Bongiorno MR, Pistone G, Memeo L, Colarossi L, Giuffrida D, Colarossi C, Vigneri P, Todaro M, Stassi G. Veschi V, et al. Nat Commun. 2023 Mar 11;14(1):1351. doi: 10.1038/s41467-023-36922-1. Nat Commun. 2023. PMID: 36906579 Free PMC article.

3

Enhancing Radioiodine Incorporation into Radioiodine-Refractory Thyroid Cancer with MAPK Inhibition (ERRITI): A Single-Center Prospective Two-Arm Study.

Weber M, Kersting D, Riemann B, Brandenburg T, Führer-Sakel D, Grünwald F, Kreissl MC, Dralle H, Weber F, Schmid KW, Herrmann K, Jentzen W, Grafe H, Rischpler C, Theurer S, Bockisch A, Nagarajah J, Fendler WP. Weber M, et al. Clin Cancer Res. 2022 Oct 3;28(19):4194-4202. doi: 10.1158/1078-0432.CCR-22-0437. Clin Cancer Res. 2022. PMID: 35594174 Free PMC article.

4

Targeting IGF2BP2 Promotes Differentiation of Radioiodine Refractory Papillary Thyroid Cancer via Destabilizing RUNX2 mRNA.

Sa R, Liang R, Qiu X, He Z, Liu Z, Chen L. Sa R, et al. Cancers (Basel). 2022 Mar 1;14(5):1268. doi: 10.3390/cancers14051268. Cancers (Basel). 2022. PMID: 35267576 Free PMC article.

5

Characterization of Subtypes of BRAF-Mutant Papillary Thyroid Cancer Defined by Their Thyroid Differentiation Score.

Boucai L, Seshan V, Williams M, Knauf JA, Saqcena M, Ghossein RA, Fagin JA. Boucai L, et al. J Clin Endocrinol Metab. 2022 Mar 24;107(4):1030-1039. doi: 10.1210/clinem/dgab851. J Clin Endocrinol Metab. 2022. PMID: 34897468 Free PMC article.

6

The Association Between Radioiodine Refractory in Papillary Thyroid Carcinoma, Sodium/Iodide Symporter Expression, and BRAF ^V600E Mutation.

Anekpuritanang T, Uataya M, Claimon A, Laokulrath N, Pongsapich W, Pithuksurachai P. Anekpuritanang T, et al. Onco Targets Ther. 2021 Jun 29;14:3959-3969. doi: 10.2147/OTT.S308910. eCollection 2021. Onco Targets Ther. 2021. PMID: 34234465 Free PMC article.

7

Validation of Immunohistochemistry for Canine Proteins Involved in Thyroid Iodine Uptake and Their Expression in Canine Follicular Cell Thyroid Carcinomas (FTCs) and FTC-Derived Organoids.

Jankovic J, Dettwiler M, Fernández MG, Tièche E, Hahn K, April-Monn S, Dettmer MS, Kessler M, Rottenberg S, Campos M. Jankovic J, et al. Vet Pathol. 2021 Nov;58(6):1172-1180. doi: 10.1177/03009858211018813. Epub 2021 May 31. Vet Pathol. 2021. PMID: 34056980

8

The molecular and gene/miRNA expression profiles of radioiodine resistant papillary thyroid cancer.

Colombo C, Minna E, Gargiuli C, Muzza M, Dugo M, De Cecco L, Pogliaghi G, Tosi D, Bulfamante G, Greco A, Fugazzola L, Borrello MG. Colombo C, et al. J Exp Clin Cancer Res. 2020 Nov 16;39(1):245. doi: 10.1186/s13046-020-01757-x. J Exp Clin Cancer Res. 2020. PMID: 33198784 Free PMC article.

9

Iodide Transporters in the Endometrium: A Potential Diagnostic Marker for Women with Recurrent Pregnancy Failures.

Bilal MY, Dambaeva S, Brownstein D, Kwak-Kim J, Gilman-Sachs A, Beaman KD. Bilal MY, et al. Med Princ Pract. 2020;29(5):412-421. doi: 10.1159/000508309. Epub 2020 Apr 30. Med Princ Pract. 2020. PMID: 32353856 Free PMC article.

10

Do BRAFV600E mutation and sodium-iodide symporter expression affect the response to radioactive iodine therapy in patients with papillary thyroid carcinoma?

Makboul R, Mostafa NM, El-Deek HEM, Aboulhagag NA, Shehata MR, Abdelhafez YG. Makboul R, et al. Nucl Med Commun. 2020 May;41(5):416-425. doi: 10.1097/MNM.0000000000001171. Nucl Med Commun. 2020. PMID: 32168263

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

160 results

Results by year